Effect of S100A8 and S100A9 on expressions of cytokine and skin barrier protein in human keratinocytes

  • Authors:
    • Mun Jeong Kim
    • Mi Ae Im
    • Ji‑Sook Lee
    • Ji Young Mun
    • Da Hye Kim
    • Ayoung Gu
    • In Sik Kim
  • View Affiliations

  • Published online on: July 1, 2019     https://doi.org/10.3892/mmr.2019.10454
  • Pages: 2476-2483
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Atopic dermatitis (AD) is an inflammatory skin disorder caused by immunological dysregulation and genetic factors. Whether the expression levels of cytokine and skin barrier protein were altered by S100 calcium binding protein A8 (S100A8) and S100A9 in human keratinocytic HaCaT cells was examined in the present study. Alterations of cytokine expression were examined by ELISA following treatment with S100A8/9 and various signal protein‑specific inhibitors. Activation of the mitogen activated protein kinase (MAPK) pathway and nuclear factor (NF)‑κB was evaluated by using western blotting and an NF‑κB activity test, respectively. The expression levels of interleukin (IL)‑6, IL‑8 and monocyte chemoattractant protein‑1 increased following treatment with S100A8 and S100A9, and the increase was significantly blocked by specific signaling pathway inhibitors, including toll‑like receptor 4 inhibitor (TLR4i), rottlerin, PD98059, SB203580 and BAY‑11‑7085. Extracellular signal‑regulated kinase (ERK) and p38 MAPK pathways were activated in a time‑dependent manner following treatment with S100A8 and S100A9. Phosphorylation of ERK and p38 MAPK were blocked by TLR4i and rottlerin. S100A8 and S100A9 induced translocation of NF‑κB in a time‑dependent manner, and the activation of NF‑κB was inhibited by TLR4i, rottlerin, PD98059 and SB203580. In addition, S100A8 and S100A9 decreased the expression of skin barrier proteins, filaggrin and loricrin. These results may help to elucidate the pathogenic mechanisms of AD and develop clinical strategies for controlling AD.

References

1 

Spergel JM and Paller AS: Atopic dermatitis and the atopic march. J Allergy Clin Immunol. 112 (6 Suppl):S118–S127. 2003. View Article : Google Scholar : PubMed/NCBI

2 

Bieber T: Atopic dermatitis. N Engl J Med. 358:1483–1494. 2008. View Article : Google Scholar : PubMed/NCBI

3 

Kim EH, Lee JS, Lee NR, Baek SY, Kim EJ, Lee SJ and Kim IS: Regulation of constitutive neutrophil apoptosis due to house dust mite allergen in normal and allergic rhinitis subjects. PLoS One. 9:e1058142014. View Article : Google Scholar : PubMed/NCBI

4 

Goyette J and Geczy CL: Inflammation-associated S100 proteins new mechanisms that regulate function. Amino Acids. 41:821–842. 2011. View Article : Google Scholar : PubMed/NCBI

5 

Kim IS and Lee JS: Anti-apoptotic Effects of house dust mite. S100A8 and S100A9 on spontaneous apoptosis of neutrophils in coculture with immune cells and in the presence of T helper cytokines. Biomed Sci Lett. 21:122–125. 2015. View Article : Google Scholar

6 

Nacken W, Roth J, Sorg C and Kerkhoff C: S100A8/S100A9: Myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc Res Tech. 60:569–580. 2003. View Article : Google Scholar : PubMed/NCBI

7 

Foell D and Roth J: Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum. 50:3762–3771. 2004. View Article : Google Scholar : PubMed/NCBI

8 

Kim IS, Kim DH, Yun CY and Lee JS: A (S)-(+)-decursin derivative, (S)-(+)-3-(3,4-dihydroxy-phenyl)-acrylic acid 2,2-dimethyl-8-oxo-3,4-dihydro-2H,8H-pyrano[3,2-g]-chromen-3-yl-ester, attenuates the development of atopic dermatitis-like lesions in NC/Nga mice. Mol Biol Rep. 40:2541–2548. 2013. View Article : Google Scholar : PubMed/NCBI

9 

Kim IS, Kim MJ, Shin DH, Son KH, Park HY and Lee JS: Arazyme inhibits cytokine expression and upregulates skin barrier protein expression. Mol Med Rep. 8:551–556. 2013. View Article : Google Scholar : PubMed/NCBI

10 

Kim DH, Choi E, Lee JS, Lee NR, Baek SY, Gu A, Kim DH and Kim IS: House dust mite allergen regulates constitutive apoptosis of normal and asthmatic neutrophils via Toll-like receptor 4. PLoS One. 10:e01259832015. View Article : Google Scholar : PubMed/NCBI

11 

Bando M, Zou X, Hiroshima Y, Kataoka M, Ross KF, Shinohara Y, Nagata T, Herzberg MC and Kido J: Mechanism of interleukin-1α transcriptional regulation of S100A9 in a human epidermal keratinocyte cell line. Biochim Biophys Acta. 1829:954–962. 2013. View Article : Google Scholar : PubMed/NCBI

12 

Zhong A, Xu W, Zhao J, Xie P, Jia S, Sun J, Galiano RD, Mustoe TA and Hong SJ: S100A8 and S100A9 are induced by decreased hydration in the epidermis and promote fibroblast activation and fibrosis in the dermis. Am J Pathol. 186:109–122. 2016. View Article : Google Scholar : PubMed/NCBI

13 

Jin S, Park CO, Shin JU, Noh JY, Lee YS, Lee NR, Kim HR, Noh S, Lee Y, Lee JH and Lee KH: DAMP molecules S100A9 and S100A8 activated by IL-17A and house-dust mites are increased in atopic dermatitis. Exp Dermatol. 23:938–941. 2014. View Article : Google Scholar : PubMed/NCBI

14 

Sakaguchi M, Yamamoto M, Miyai M, Maeda T, Hiruma J, Murata H, Kinoshita R, Winarsa Ruma IM, Putranto EW, Inoue Y, et al: Identification of an S100A8 receptor neuroplastin-β and its heterodimer formation with EMMPRIN. J Invest Dermatol. 136:2240–2250. 2016. View Article : Google Scholar : PubMed/NCBI

15 

Kim IS, Song GY, Kim DH, Cho SH, Yun CY and Lee JS: Effect of (E)-2-(3,4-dimethoxyphenyl)-4-oxo-4H-chromen-7-yl-3-(3,4-dimethoxyphenyl) acrylate on the development of atopic dermatitis-like lesions. Life Sci. 91:338–344. 2012. View Article : Google Scholar : PubMed/NCBI

16 

Benedyk M, Sopalla C, Nacken W, Bode G, Melkonyan H, Banfi B and Kerkhoff C: HaCaT keratinocytes overexpressing the S100 proteins S100A8 and S100A9 show increased NADPH oxidase and NF-kappaB activities. J Invest Dermatol. 127:2001–2011. 2007. View Article : Google Scholar : PubMed/NCBI

17 

Cha KJ, Im MA, Gu A, Kim DH, Lee D, Lee JS, Lee JS and Kim IS: Inhibitory effect of Patrinia scabiosifolia Link on the development of atopic dermatitis-like lesions in human keratinocytes and NC/Nga mice. J Ethnopharmacol. 206:135–143. 2017. View Article : Google Scholar : PubMed/NCBI

18 

Sakai T, Hatano Y, Zhang W, Fujiwara S and Nishiyori R: Knockdown of either filaggrin or loricrin increases the productions of interleukin (IL)-1α, IL-8, IL-18 and granulocyte macrophage colony-stimulating factor in stratified human keratinocytes. J Dermatol Sci. 80:158–160. 2015. View Article : Google Scholar : PubMed/NCBI

19 

Ilves T, Tiitu V, Suttle MM, Saarinen JV and Harvima IT: Epidermal expression of filaggrin/profilaggrin is decreased in atopic dermatitis: Reverse association with mast cell tryptase and IL-6 but not with clinical severity. Dermatitis. 26:260–267. 2015. View Article : Google Scholar : PubMed/NCBI

20 

Chang L and Karin M: Mammalian MAP Kinase signaling cascades. Nature. 410:33–40. 2011.

21 

Park JH, Kim MS, Jeong GS and Yoon J: Xanthii fructus extract inhibits TNF-α/IFN-γ-induced Th2-chemokines production via blockade of NF-κB, STAT1 and p38-MAPK activation in human epidermal keratinocytes. J Ethnopharmacol. 171:85–93. 2015. View Article : Google Scholar : PubMed/NCBI

22 

Lee NR, Park BS, Kim SY, Gu A, Kim DH, Lee JS and Kim IS: Cytokine secreted by S100A9 via TLR4 in monocytes delays neutrophil apoptosis by inhibition of caspase 9/3 pathway. Cytokine. 86:53–63. 2016. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

September 2019
Volume 20 Issue 3

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Kim, M.J., Im, M.A., Lee, J., Mun, J.Y., Kim, D.H., Gu, A., & Kim, I.S. (2019). Effect of S100A8 and S100A9 on expressions of cytokine and skin barrier protein in human keratinocytes. Molecular Medicine Reports, 20, 2476-2483. https://doi.org/10.3892/mmr.2019.10454
MLA
Kim, M. J., Im, M. A., Lee, J., Mun, J. Y., Kim, D. H., Gu, A., Kim, I. S."Effect of S100A8 and S100A9 on expressions of cytokine and skin barrier protein in human keratinocytes". Molecular Medicine Reports 20.3 (2019): 2476-2483.
Chicago
Kim, M. J., Im, M. A., Lee, J., Mun, J. Y., Kim, D. H., Gu, A., Kim, I. S."Effect of S100A8 and S100A9 on expressions of cytokine and skin barrier protein in human keratinocytes". Molecular Medicine Reports 20, no. 3 (2019): 2476-2483. https://doi.org/10.3892/mmr.2019.10454